{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:50:09Z","timestamp":1791111009098,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,8]],"date-time":"2010-01-08T00:00:00Z","timestamp":1262908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2010,1,8]],"date-time":"2010-01-08T00:00:00Z","timestamp":1262908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Recent, international declines in breast cancer incidence are unprecedented, and the causes remain controversial. Few data sources can address breast cancer incidence trends according to pertinent characteristics like hormone therapy use history.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>We used the prospective California Teachers Study to evaluate changes in self-reported use of menopausal hormone therapy (HT) between 1995 to 1996 and 2005 to 2006 and age-adjusted breast cancer incidence among 74,647 participants aged 50 years or older. Breast cancer occurrence was determined by linkage with the California Cancer Registry.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>During 517,286 woman years of follow up, 565 <jats:italic>in situ<\/jats:italic> and 2,668 invasive breast cancers were diagnosed. <jats:italic>In situ<\/jats:italic> breast cancer incidence rates in this population did not change significantly from 2000 to 2002 to 2003 to 2005, whereas rates of invasive breast cancer declined significantly by 26.0% from 528.0 (95% confidence intervals (CI) = 491.1, 564.9) per 100,000 women in 2000 to 2002 to 390.6 (95% CI = 355.6, 425.7) in 2003 to 2005. The decline in invasive breast cancer incidence rates was restricted to estrogen receptor-positive tumors. In 1996 to 1999 and 2000 to 2002 invasive breast cancer incidence was higher for women who reported current HT use especially estrogen-progestin (EP) use at baseline than for never or past users; but by 2003 to 2005 rates were comparable between these groups. For women who were taking EP in 2001 to 2002,75% of whom had stopped use by 2005 to 2006, incidence had declined 30.6% by 2003 to 2005 (<jats:italic>P<\/jats:italic> = 0.001); whereas incidence did not change significantly for those who never took HT (<jats:italic>P<\/jats:italic> = 0.33).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Few data resources can examine prospectively individual HT use and breast cancer diagnosis. Stable <jats:italic>in situ<\/jats:italic> breast cancer rates imply consistent levels of screening and suggest recent declines in invasive breast cancer to be explained predominantly by changes in HT use.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr2467","type":"journal-article","created":{"date-parts":[[2010,1,8]],"date-time":"2010-01-08T21:31:24Z","timestamp":1262986284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort"],"prefix":"10.1186","volume":"12","author":[{"given":"Sarah F","family":"Marshall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Deapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Largent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L","family":"Neuhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giske","family":"Ursin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L","family":"Horn-Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel O","family":"Stram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Templeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,8]]},"reference":[{"key":"2431_CR1","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1200\/JCO.2007.11.4132","volume":"25","author":"AS Robbins","year":"2007","unstructured":"Robbins AS, Clarke CA: Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004. J Clin Oncol. 2007, 25: 3437-3439. 10.1200\/JCO.2007.11.4132.","journal-title":"J Clin Oncol"},{"key":"2431_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJMsr070105","volume":"356","author":"PM Ravdin","year":"2007","unstructured":"Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA: The decrease in breast cancer incidence in 2003 in the United States. N Engl J Med. 2007, 356: 1670-1674. 10.1056\/NEJMsr070105.","journal-title":"N Engl J Med"},{"key":"2431_CR3","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/jnci\/djm059","volume":"99","author":"AG Glass","year":"2007","unstructured":"Glass AG, Lacey JV, Carreon JD, Hoover RN: Breast cancer incidence, 1986-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007, 99: 1152-1161. 10.1093\/jnci\/djm059.","journal-title":"J Natl Cancer Inst"},{"key":"2431_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/jnci\/djm111","volume":"99","author":"K Kerlikowske","year":"2007","unstructured":"Kerlikowske K, Miglioretti DL, Buist DSM, Walker R, Carney PA: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2007, 99: 1335-1339. 10.1093\/jnci\/djm111.","journal-title":"J Natl Cancer Inst"},{"key":"2431_CR5","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1158\/1055-9965.EPI-07-0546","volume":"16","author":"CI Li","year":"2007","unstructured":"Li CI, Daling JR: Changes in breast cancer incidence rates in the United States by histologic subtype and race\/ethnicity, 1995-2004. Cancer Epidemiol Biomarkers Prev. 2007, 16: 2773-2780. 10.1158\/1055-9965.EPI-07-0546.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2431_CR6","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1200\/JCO.2006.08.6504","volume":"24","author":"CA Clarke","year":"2006","unstructured":"Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ: Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006, 24: e49-e50. 10.1200\/JCO.2006.08.6504.","journal-title":"J Clin Oncol"},{"key":"2431_CR7","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/bcr1672","volume":"9","author":"A Jemal","year":"2007","unstructured":"Jemal A, Ward E, Thun MJ: Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res. 2007, 9: R28-10.1186\/bcr1672.","journal-title":"Breast Cancer Res"},{"key":"2431_CR8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5694\/j.1326-5377.2008.tb01821.x","volume":"188","author":"K Canfell","year":"2008","unstructured":"Canfell K, Banks E, Moa AM, Beral V: Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Australia. 2008, 188: 641-644.","journal-title":"Med J Australia"},{"key":"2431_CR9","first-page":"11","volume":"95","author":"H Allemand","year":"2008","unstructured":"Allemand H, Seradour B, Weill A, Ricordeau P: Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend. Bull Cancer. 2008, 95: 11-15.","journal-title":"Bull Cancer"},{"key":"2431_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10549-007-9566-z","volume":"107","author":"A Katalinic","year":"2007","unstructured":"Katalinic A, Rawal R: Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat. 2007, 107: 427-430. 10.1007\/s10549-007-9566-z.","journal-title":"Breast Cancer Res Treat"},{"key":"2431_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMc071391","volume":"357","author":"EV Kliewer","year":"2007","unstructured":"Kliewer EV, Demers AA, Nugent ZJ: A decline in breast-cancer incidence. N Engl J Med. 2007, 357: 509-510. 10.1056\/NEJMc071391.","journal-title":"N Engl J Med"},{"key":"2431_CR12","volume-title":"New Zealand Herald","author":"M Johnston","year":"2006","unstructured":"Johnston M: Breast cancer drop linked to fall in use of HRT. New Zealand Herald. 2006, [http:\/\/www.nzherald.co.nz\/section\/story.cfm?c_id=204&objectid=10416198]"},{"key":"2431_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0140-6736(08)61255-6","volume":"372","author":"M Kumle","year":"2008","unstructured":"Kumle M: Declining breast cancer incidence and decreased HRT use. Lancet. 2008, 372: 608-610. 10.1016\/S0140-6736(08)61255-6.","journal-title":"Lancet"},{"key":"2431_CR14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/jech.2005.033316","volume":"59","author":"N Krieger","year":"2005","unstructured":"Krieger N, Lowy I, Aronowitz R, Bigby J, Dickersin K, Garner E, Gaudilli\u00e8re JP, Hinestrosa C, Hubbard R, Johnson PA, Missmer SA, Norsigian J, Pearson C, Rosenberg CE, Rosenberg L, Rosenkrantz BG, Seaman B, Sonnenschein C, Soto AM, Thornton J, Weisz G: Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. J Epidemiol Community Health. 2005, 59: 740-748. 10.1136\/jech.2005.033316.","journal-title":"J Epidemiol Community Health"},{"key":"2431_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.291.1.47","volume":"291","author":"AL Hersh","year":"2004","unstructured":"Hersh AL, Stefanick ML, Stafford RS: National use of postmenopausal hormone therapy: Annual trends and response to recent evidence. JAMA. 2004, 291: 47-53. 10.1001\/jama.291.1.47.","journal-title":"JAMA"},{"key":"2431_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","unstructured":"Writing Group for the Women's Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002, 288: 321-333. 10.1001\/jama.288.3.321.","journal-title":"JAMA"},{"key":"2431_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1023\/A:1019552126105","volume":"13","author":"L Bernstein","year":"2002","unstructured":"Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A, Ross RK: High breast cancer incidence rates among California teachers: results from the California Teachers Study United States. Cancer Causes Control. 2002, 13: 625-635. 10.1023\/A:1019552126105.","journal-title":"Cancer Causes Control"},{"key":"2431_CR18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/jnci\/dji140","volume":"97","author":"SF Marshall","year":"2005","unstructured":"Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK: Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst. 2005, 97: 805-812.","journal-title":"J Natl Cancer Inst"},{"key":"2431_CR19","volume-title":"Statistical Methods in Cancer Research. Descriptive Epidemiology","author":"J Esteve","year":"1994","unstructured":"Esteve J, Benhamou E, Raymond L: Statistical Methods in Cancer Research. Descriptive Epidemiology. 1994, Lyon: International Agency for Research on Cancer, 4:"},{"key":"2431_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-8122-8","volume-title":"Simultaneous Statistical Inference","author":"RG Miller","year":"1981","unstructured":"Miller RG: Simultaneous Statistical Inference. 1981, New York: Springer-Verlag, 2","edition":"2"},{"key":"2431_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s10552-007-9029-1","volume":"18","author":"CA Clarke","year":"2007","unstructured":"Clarke CA, Glaser SL: Declines in breast cancer after the WHI: apparent impact of hormone therapy. Cancer Causes Control. 2007, 18: 847-852. 10.1007\/s10552-007-9029-1.","journal-title":"Cancer Causes Control"},{"key":"2431_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.0.CO;2-Q","volume":"86","author":"L Tab\u00e1r","year":"1999","unstructured":"Tab\u00e1r L, Duffy SW, Vitak B, Chen H, Prevost TC: The natural history of breast carcinoma. Cancer. 1999, 86: 449-462. 10.1002\/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.0.CO;2-Q.","journal-title":"Cancer"},{"key":"2431_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","volume":"362","author":"V Beral","year":"2003","unstructured":"Beral V: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003, 362: 419-427. 10.1016\/S0140-6736(03)14596-5.","journal-title":"Lancet"},{"key":"2431_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0140-6736(09)60165-3","volume":"373","author":"DH Brewster","year":"2009","unstructured":"Brewster DH, Sharpe KH, Clark DI, Collins J: Declining breast cancer incidence and decreased HRT use. Lancet. 2009, 373: 459-460. 10.1016\/S0140-6736(09)60165-3.","journal-title":"Lancet"},{"key":"2431_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10549-007-9554-3","volume":"107","author":"HM Verkooijen","year":"2008","unstructured":"Verkooijen HM, Koot VCM, Fioretta G, Heiden van der M, Schipper ME, Rapiti E, Peeters PH, Peterse JL, Bouchardy C: Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations. Breast Cancer Res Treat. 2008, 107: 389-395. 10.1007\/s10549-007-9554-3.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2467.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr2467\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2467.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:42:51Z","timestamp":1728384171000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr2467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,8]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,2]]}},"alternative-id":["2431"],"URL":"https:\/\/doi.org\/10.1186\/bcr2467","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,8]]},"assertion":[{"value":"7 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R4"}}